Search | trudellmed.com

Based on your language, we suggest to change your settings to: En fonction de votre langue, nous vous suggérons de modifier vos paramètres comme suit :

Yes, that's correct Oui, c'est correct.

Search

Aerobika

AEROBIKA* OPEP Device

A drug-free and easy to use device that can help open weak airways and to loosen mucus, so it can be coughed out.

Medikro to distribute Aerobika* OPEP Devices to patients in Finland and Sweden.

Medikro to distribute Aerobika* OPEP Devices to patients in Finland and Sweden.

How can time to COPD exacerbation be delayed? A Real-World Study Comparing Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis

COPD/chronic bronchitis patients given an Aerobika* OPEP device compared to an alternative OPEP device had delayed time to re-admission. This supports use of the Aerobika* OPEP device as an add-on to usual care post-exacerbation and highlights differences in OPEP device effectiveness.

A Retrospective Cohort Study Comparing the Impact of Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis on Hospital Readmissions at 30 Days and 12 Months

Results from this study demonstrate a reduction in the proportion of patients requiring COPD/chronic bronchitis related readmission within 30 days and 12 months of the Aerobika^® OPEP device therapy initiation compared to an alternative OPEP device.
This further supports the use of the Aerobika^® OPEP device as an add-on to usual care to manage COPD/chronic bronchitis patients post-exacerbation and highlights that not all OPEP devices are the same in terms of 30-day and 12-month readmissions

How can time to COPD exacerbation be delayed? A Real-World Study Comparing Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis

Conclusions:

COPD/chronic bronchitis patients given an Aerobika* OPEP device compared to an alternative OPEP device had delayed time to re-admission. This supports use of the Aerobika* OPEP device as an add-on to usual care post-exacerbation and highlights differences in OPEP device effectiveness.

A Retrospective Cohort Study Comparing the Impact of Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis on Hospital Readmissions at 30 Days and 12 Months

Results from this study demonstrate a reduction in the proportion of patients requiring COPD/chronic bronchitis related readmission within 30 days and 12 months of the Aerobika^® OPEP device therapy initiation compared to an alternative OPEP device.
This further supports the use of the Aerobika^® OPEP device as an add-on to usual care to manage COPD/chronic bronchitis patients post-exacerbation and highlights that not all OPEP devices are the same in terms of 30-day and 12-month readmissions

Assessment of the Clinical Value of an Oscillating Positive Expiratory Pressure (OPEP) device and Active Cycle of Breathing (ACBT) for Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation

This study assessed people with COPD suffering with mucus hypersecretion, post exacerbation in Wales, UK, following treatment with a handheld, OPEP device or the ACBT breathing technique.

Truzone peak flow meter viewed on an angle

TRUZONE* Peak Flow Meter

A portable and inexpensive device that is used to measure how well air moves out of your lungs.

Patient Centered Considerations when Selecting an Oscillating Positive Expiratory Pressure (OPEP) Device

Efficacy is a major aspect when selecting an OPEP device for airway clearance.

This study was presented at the North American Cystic Fibrosis Conference 2022.

Combining Drug Delivery via Breath Actuated Nebulizer with Exhalation Through An Oscillating Positive Expiratory Pressure Device — The Potential For Optimal Combined Therapy

Conclusion

The delivery of medication from the AEROECLIPSE* II BAN* to the lungs was not affected by the incorporation of the Aerobika* OPEP device. Aerosol deposition within the lung was unaltered by the addition of the OPEP device as evidenced by the near identical percentage of the dose being deposited in both the peripheral and central airways.
BAN+OPEP therapy could offer the clinician the opportunity for combined treatment thereby reducing the time needed for the patient to take both nebulizer and OPEP treatments separately.

A National Audit of the Aerobika* Oscillatory Positive Pressure Device When Used to Assist Airway Clearance for Those With Cystic Fibrosis, Bronchiectasis and COPD

Patient use & evaluations of Aerobika* device across 23 UK Centres

RESULT: Improved CAT scores, 92% patients continuing Tx, 87% HCP (very) happy.

A National Audit of the Aerobika* Oscillatory Positive Pressure Device When Used to Assist Airway Clearance for Those With Cystic Fibrosis, Bronchiectasis and COPD

Patient use & evaluations of Aerobika* device across 23 UK Centres

RESULT: Improved CAT scores, 92% patients continuing Tx, 87% HCP (very) happy.

Significant reductions in costly pulmonary complications with use of drug-free device

Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system. A new real-world study published in Pulmonary Therapy, indicates significant reductions in costs when using the AEROBIKA*oscillating positive expiratory pressure (OPEP) device in the postoperative care setting.¹

A laboratory assessment of nebulized medication delivery through different Oscillating Positive Expiratory Pressure (OPEP) devices - not all devices are the same

Medications to manage care of bronchiectasis and NTM patients are often delivered via a nebulizer. This study compares a number of different OPEP/Nebulizer combinations using salbutamol as the modelled medication.

A laboratory assessment of nebulized medication delivery through different Oscillating Positive Expiratory Pressure (OPEP) devices - not all devices are the same

Medications to manage care of bronchiectasis and NTM patients are often delivered via a nebulizer. This study compares a number of different OPEP/Nebulizer combinations using salbutamol as the modelled medication.

Laboratory Investigation into the Performance of Four Oscillating Positive Expiratory Pressure (OPEP) Devices set at Target Pressure Level

This laboratory study compared the performance of four different OPEP devices, each utilizing distinctly different mechanisms to generate oscillatory pressure.

Elderly woman looks happy

Determining the Best Inhaled Delivery Devices for your Patients

Join Dr. Sacha Bhinder, HBSc, MD, FRCPC, for a review of inhaled delivery device products that are available in Canada, and how to foster customized care when choosing the most appropriate device for your patient.

Objectives of the Presentation

✓ Review recommended treatments for Asthma & COPD Management.

✓ Learn about the necessity of selecting the right inhaler for the individual patient.

✓ Understand how correct inhaler technique can improve medication delivery.

Patient Centered Considerations when Selecting an Oscillating Positive Expiratory Pressure (OPEP) Device

Efficacy is a major aspect when selecting an OPEP device for airway clearance.

This study was presented at the North American Cystic Fibrosis Conference 2022.

Failure of Mycobacterium avium to Adhere to Interior Surfaces of Oscillating Positive Expiratory Pressure (OPEP) and Nebulizer Devices

The objective of this study was to measure the adherence of M. avium cells to the interior walls of two commonly used respiratory devices.

MyAEROBIKA* Reminder Program

Thank you for investing in your AEROBIKA* OPEP Device!

Product Resources for Healthcare Professionals

View our product videos, download our how-to-use instructions, and counseling materials.

Assessment of Two Oscillating Positive Expiratory Pressure (OPEP) Devices: How do the Differing Mechanisms of Action Impact Lab Performance

This study was presented at the British Thoracic Society Winter Meeting 2022.

The Clinical Value of an Oscillating Positive Expiratory Pressure (OPEP) Device for Chronic Obstructive Pulmonary Disease (COPD)

This study was presented at the American Thoracic Society Conference in 2023.

The Impact of an Oscillating Positive Expiratory Pressure (OPEP) Device on Mucus Plugs: A Case Study Using Functional Respiratory Imaging (FRI) and a COPD patient

Given the more recent availability of mucus plug detection as part of the FRI technology, we wanted to investigate this association further.